NEW YORK, Oct. 22 (GenomeWeb News) - Affymetrix reported revenues of $76.2 million for the third quarter today, up from $ 72.7 million for the same period last year.

These revenues included $71.1 million in product revenue, compared to $62.9 million for the third quarter of 2002.

The company’s net income rose with revenues, to $5.8 million for the quarter, compared to $0.6 million for the same period last year. This is the third consecutive quarter of profitability for the Santa Clara, Calif. microarray company.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.